EVE RSANA expanded its AI-powered commercialization platform with medical information and market research capabilities. The company said the upgraded platform now includes tools for medical affairs workflow support, MLR automation, and analytics for commercial teams, moving beyond earlier marketing-centric pilots. Chief Executive Officer Mark Thierer said the expansion reflects an “inflection point” where pharma buyers want scalable AI integrated into governed, compliance-ready operating models. For biotech and pharma services providers, the announcement highlights growing appetite for AI orchestration and workflow automation across downstream functions—not just discovery.